Anti-Human CD18 Recombinant Antibody

Product Information

Catalog Number	YR1184
Product Name	Anti-Human CD18 Recombinant Antibody
Molecular Name	Erlizumab
Alias	Anti-CD18 Recombinant Antibody, Research Grade Erlizumab
CAS Number	211323-03-4
Target	CD18[Homo sapiens]
Isotype	IgG1
Clonity	Monoclonal
Host	Mouse
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, FCM, IP, FuncS, IF, Neut, ICC
Buffer	PBS, pH7.5
Background	Erlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price